Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Nektar Therapeutics Exercises License Option with Biolojic Design for AI-Crafted Agonistic Antibody Aimed at TNFR2 to Treat Autoimmune Diseases

Thursday, April 25, 2024

Biolojic Design a biotech company specializing in AIdriven antibody innovation announced that Nektar has exercised its license option to develop a program resulting from their collaborative research started in

Amneal Secures FDA Approval for OTC Naloxone Hydrochloride Nasal Spray to Treat Opioid Overdose Emergencies

Thursday, April 25, 2024

Amneal Pharmaceuticals Inc has unveiled its Over the Counter Naloxone Hydrochloride Nasal Spray USP mg after securing Abbreviated New Drug Application approval from the US Food and Drug Administration

Hanmi Enters Clinical Trial Collaboration and Supply Pact with MSD to Assess BH3120 with KEYTRUDA®

Wednesday, April 24, 2024

Hanmi Pharmaceutical a leading biopharmaceutical company headquartered in Korea with a focus on oncology obesitymetabolism and rare diseases has recently announced a significant collaboration

GenScript Singapore Hosts Open Day Showcasing Cutting-Edge AI Advancements in Recombinant Protein Production and Drug Discovery

Wednesday, April 24, 2024

GenScript a prominent player in the field of life sciences and biotechnology recently hosted an Open Day event at its facility in Singapore on April th The event attracted more than representatives from Singapore

BeiGene's Tislelizumab Granted European Commission Approval for Non-Small Cell Lung Cancer Treatment

Wednesday, April 24, 2024

BeiGene Ltd has received approval from the European Commission for tislelizumabs usage in treating nonsmall cell lung cancer across three distinct indications encompassing both first and secondline

OSR Holdings and SillaJen Collaborate to Develop New Therapies and Expand into the U.S. Market

Tuesday, April 23, 2024

OSR Holdings a significant global healthcare holding company has recently announced the signing of a memorandum of understanding with SillaJen a biotech firm listed on Kosdaq and renowned for its pipeline

Enlivex Initiates Dosing of Initial Two Patients in Phase I/II Trial to Evaluate Allocetra™ for Knee Osteoarthritis

Tuesday, April 23, 2024

Enlivex Therapeutics Ltd has commenced dosing for the initial two patients in its Phase III trial evaluating AllocetraTM for moderate to severe knee osteoarthritis This multicountry trial aims

BGI Genomics Launches First Clinical Laboratory in Uruguay, Spearheading Innovation

Monday, April 22, 2024

BGI Genomics a renowned leader in precision medicine solutions has launched a cuttingedge clinical laboratory in Uruguays Parque de las Ciencias free trade zone This move is poised to advance preventive

ProQR Successfully Protects Axiomer™ IP Portfolio from New Challenge

Saturday, April 20, 2024

ProQR Therapeutics NV has once again successfully defended a crucial patent for its groundbreaking RNA editing platform Axiomer This achievement follows the companys victory in fending off opposition against its key patent EP B filed with the Euro...

Tiziana Life Sciences Reveals Results of Study on Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients, Highlighting PIRA Significance in Neurology Today®

Saturday, April 20, 2024

Tiziana Life Sciences Ltd recently announced a significant development regarding its lead candidate foralumab in a study highlighted by Neurology Today the official news source of the American Academy